CNO 📈 CNO Financial - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12621E1038
CNO: Health Insurance, Annuities, Life Insurance, Financial Services
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana. Web URL: https://www.cnoinc.com
Additional Sources for CNO Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNO Stock Overview
Market Cap in USD | 3,951m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1987-01-01 |
CNO Stock Ratings
Growth 5y | 78.1% |
Fundamental | 15.8% |
Dividend | 60.0% |
Rel. Strength Industry | 10.9 |
Analysts | 3/5 |
Fair Price Momentum | 40.40 USD |
Fair Price DCF | 153.76 USD |
CNO Dividends
Dividend Yield 12m | 1.28% |
Yield on Cost 5y | 2.87% |
Annual Growth 5y | 6.53% |
Payout Consistency | 100.0% |
CNO Growth Ratios
Growth Correlation 3m | 71.6% |
Growth Correlation 12m | 89.5% |
Growth Correlation 5y | 78.8% |
CAGR 5y | 17.49% |
CAGR/Mean DD 5y | 1.48 |
Sharpe Ratio 12m | 1.07 |
Alpha | 2.11 |
Beta | 1.30 |
Volatility | 48.87% |
Current Volume | 1833.6k |
Average Volume 20d | 743.9k |
What is the price of CNO stocks?
As of December 21, 2024, the stock is trading at USD 36.78 with a total of 1,833,632 shares traded.
Over the past week, the price has changed by -3.29%, over one month by -4.88%, over three months by +4.48% and over the past year by +36.56%.
As of December 21, 2024, the stock is trading at USD 36.78 with a total of 1,833,632 shares traded.
Over the past week, the price has changed by -3.29%, over one month by -4.88%, over three months by +4.48% and over the past year by +36.56%.
Is CNO Financial a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, CNO Financial is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNO as of December 2024 is 40.40. This means that CNO is currently overvalued and has a potential downside of 9.84%.
Neither. Based on ValueRay Fundamental Analyses, CNO Financial is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNO as of December 2024 is 40.40. This means that CNO is currently overvalued and has a potential downside of 9.84%.
Is CNO a buy, sell or hold?
CNO Financial has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold CNO.
CNO Financial has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold CNO.
- Strong Buy: 0
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecast for CNO stock price target?
According to ValueRays Forecast Model, CNO CNO Financial will be worth about 43.7 in December 2025. The stock is currently trading at 36.78. This means that the stock has a potential upside of +18.84%.
According to ValueRays Forecast Model, CNO CNO Financial will be worth about 43.7 in December 2025. The stock is currently trading at 36.78. This means that the stock has a potential upside of +18.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 39.6 | 7.7% |
Analysts Target Price | 25.6 | -30.4% |
ValueRay Target Price | 43.7 | 18.8% |